Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000675413 | SCV001102235 | benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV001288190 | SCV001475139 | benign | not specified | 2020-08-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000675413 | SCV001869934 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000675413 | SCV002563418 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | GFAP: BP4, BP7, BS1, BS2 |
Prevention |
RCV003940278 | SCV004749395 | benign | GFAP-related condition | 2019-07-02 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Mayo Clinic Laboratories, |
RCV000675413 | SCV000801090 | likely benign | not provided | 2018-02-07 | no assertion criteria provided | clinical testing |